HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Hepatitis C
Liver disease
Liver Cancer
DOI:
10.1053/j.gastro.2019.02.038
Publication Date:
2019-03-02T15:36:04Z
AUTHORS (35)
ABSTRACT
Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatocellular carcinoma (HCC). Despite effective antiviral therapies, the HCC decreased but not eliminated after a sustained virologic response (SVR) to direct-acting (DAA) agents, and higher in patients with advanced fibrosis. We investigated HCV-induced epigenetic alterations that might affect DAA treatment mice humanized livers.We performed genome-wide ChIPmentation-based ChIP-Seq RNA-seq analyses of liver tissues from 6 without HCV (controls), 18 chronic infection, 8 cured by treatment, 13 interferon therapy, 4 B 7 nonalcoholic steatohepatitis Europe Japan. modifications were mapped comparative associated other disease etiologies. uPA/SCID engrafted human hepatocytes create livers given injections HCV-infected serum samples patients; DAAs eradicate virus. Pathways identified integrative pathway validated paired SVR infection.We found induce specific changes H3K27ac, which correlated expression mRNAs proteins. These persisted or interferon-based therapies. Integrative demonstrated cancer risk. Computational increased SPHK1 these findings independent cohort HCV-related cirrhosis (n = 216), subset 21) achieved viral clearance.In analysis we gene HCC. be targeted prevent treated infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (219)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....